Prøve GULL - Gratis
Why a ₹1-crore health cover matters—and how to buy it
Mint Bangalore
|June 13, 2025
What to watch out for while upgrading your health insurance policy amid rising medical cost
In 2016, Hyderabad-based Ankur Pathak's mother-in-law was diagnosed with Stage-III ovarian cancer, barely a month or two after undergoing angioplasty. The back-to-back medical emergencies left the family with limited funds to manage the treatment costs.
Though she had a reimbursement-based government health cover, the procedural delay and out-of-pocket expenses proved overwhelming. She passed away within three months, unable to continue chemotherapy.
The experience made Pathak realize the importance of having a strong insurance cover with adequate immediate support, regardless of employer-provided plans. He opted for ₹50 lakh base coverage, which would increase to ₹1 crore with no-claim bonuses.
More Indians are opting for ₹1-crore health covers as medical costs rise. Online insurance platform Policybazaar saw the number of such policies surge to 9,739 in 2024 from 4,427 policies in 2023. "In 2025, we've already sold 7,521 such policies by May," said Siddharth Singhal, health insurance head at Policybazaar, noting an 85% growth expectation for the year.
Why ₹1 crore?
Insurance advisors say ₹1 crore may feel excessive today, but five to 10 years down the line, it could be just about right. Medical inflation is pushing costs up fast. Data from the surgery-care company Hexa Health showed that the average severe illness claim in India doubles every 10 years.
For example, cancer treatment costs that hovered around ₹2-3 lakh in 2015 now average ₹4-6 lakh, and could touch ₹9 lakh by 2035. Meanwhile, a heart bypass that cost ₹3 lakh a decade ago may cost over ₹6 lakh by 2035.
While average treatment costs for severe illnesses provide a baseline, actual expenses often run significantly higher, especially in private hospitals and metro cities, where charges can be 2-3X the national average.
Additionally, illnesses rarely occur in isolation; follow-up treatments, diagnostics, and medications add recurring costs over time.
Denne historien er fra June 13, 2025-utgaven av Mint Bangalore.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Bangalore
Mint Bangalore
Beer makers seek relief on can norms
The domestic beer industry, which has been facing an acute shortage of aluminium cans and fearing an impact on growth trajectory, has urged the government fora ‘short-term regulatory relaxation’ in quality control norms to ensure uninterrupted supply from overseas.
1 min
October 13, 2025

Mint Bangalore
When is the ‘right’ time to quit your job?
If you leave a job too early, you risk looking impatient. On the other hand, staying too long can lead to stagnation, burnout or resentment
5 mins
October 13, 2025

Mint Bangalore
We must fight climate-change denial with scientific evidence
What Trump called a 'con job' is a real crisis that we can't dismiss
3 mins
October 13, 2025

Mint Bangalore
Differences aside, Tata Trusts keen to retain Tata Sons as unlisted firm
two executives said. Mint could not ascertain if the said trustee discussed his view with others.
1 mins
October 13, 2025
Mint Bangalore
DGCA flags RAT issues, orders Air India fleet review
India’s Aviation safety regulator Directorate General of Civil Aviation (DGCA) has directed Air India to reinspect Ram Air Turbine (RAT) stowage on all aircraft where the power conditioning module (PCM) was replaced recently.
1 mins
October 13, 2025
Mint Bangalore
Gaza: What gives Israel its courage to defy the world?
Once again, the Levant is on the verge of peace. I know what to say about how long this peace would last, but I wish to be more hopeful than prescient, even though I am a columnist. By many measures, Israel won this war.
4 mins
October 13, 2025

Mint Bangalore
Jindal's TKSE bid faces €2-3 bn pension, workforce hurdles
TKSE's European steel unit accounts for roughly half of thyssenkrupp’s pension obligations
2 mins
October 13, 2025

Mint Bangalore
ED to close Flipkart case if it pays fine
The Enforcement Directorate (ED) is learnt to have offered the option of closing a Foreign Exchange Management Act (Fema) violation case against e-commerce major Flipkart if the Walmart group firm admits its mistake and pays a penalty, sources aware of the development said.
1 min
October 13, 2025
Mint Bangalore
ACME to invest ₹5k cr in green steel
CME Group is planning to invest ₹5,000 crore to set up a direct reduced iron (DRI) facility, according to industry sources.
1 min
October 13, 2025
Mint Bangalore
Why US tariffs will not take us back to the gloomy 1930s
S President Donald Trump's tariff gambit has undeniably thrown the world into turmoil. By relying on a series of bilateral tariff bargains, he has effectively sidelined the multilateral framework of the World Trade Organization (WTO).
3 mins
October 13, 2025
Listen
Translate
Change font size